As head of Business Development for Bristol Myers Squibb, Julie oversees the company's business development activities, including mergers and acquisitions, strategic partnerships, and global alliances. Julie is a proven leader in healthcare investment banking and prior to joining Bristol Myers Squibb, she spent 20 years of her career at Morgan Stanley, with 15 years in healthcare investment banking. She has a deep understanding of the biopharmaceutical and healthcare landscapes, having advised on over 20 announced strategic transactions representing over $500B in deal value, including mergers, acquisitions, divestitures and numerous debt and equity capital raises.